Home › Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia
 

Keywords :   


Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia

2015-06-03 05:49:21| drugdiscoveryonline Home Page

Regulatory News: Weill Cornell Medical College and Cellectis have entered into a strategic translational research alliance to accelerate the development of a targeted immunotherapy for patients with acute myelogenous leukemia (AML), a deadly blood cancer

Tags: in research college medical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 37
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Wind Speed Probabilities Number 37
07.07Tropical Storm Beryl Public Advisory Number 37
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
More »